These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 15850603

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels.
    Gol M, Akan P, Dogan E, Karas C, Saygili U, Posaci C.
    Maturitas; 2006 Feb 20; 53(3):252-9. PubMed ID: 15990257
    [Abstract] [Full Text] [Related]

  • 6. The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism--results from a randomized, double-blind, clinical trial.
    Høibraaten E, Qvigstad E, Andersen TO, Mowinckel MC, Sandset PM.
    Thromb Haemost; 2001 May 20; 85(5):775-81. PubMed ID: 11372667
    [Abstract] [Full Text] [Related]

  • 7. Effect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thrombosis: a randomized, placebo-controlled study in postmenopausal women.
    Post MS, Christella M, Thomassen LG, van der Mooren MJ, van Baal WM, Rosing J, Kenemans P, Stehouwer CD.
    Arterioscler Thromb Vasc Biol; 2003 Jun 01; 23(6):1116-21. PubMed ID: 12730085
    [Abstract] [Full Text] [Related]

  • 8. Raloxifene reduces procarboxypeptidase U, an antifibrinolytic marker. A 2-year randomized, placebo-controlled study in healthy early postmenopausal women.
    Vogelvang TE, Leurs JR, van der Mooren MJ, Mijatovic V, Hendriks DF, Neele SJ, Netelenbos JC, Kenemans P.
    Menopause; 2004 Jun 01; 11(1):110-5. PubMed ID: 14716191
    [Abstract] [Full Text] [Related]

  • 9. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S, Silveira A, Hakala-Ala-Pietilä T, Virkamäki A, Hovatta O, Hamsten A, Taskinen MR, Yki-Järvinen H.
    Thromb Haemost; 2001 Apr 01; 85(4):619-25. PubMed ID: 11341495
    [Abstract] [Full Text] [Related]

  • 10. Differential effects of conventional and low dose oral hormone therapy (HT), tibolone, and raloxifene on coagulation and fibrinolysis.
    Eilertsen AL, Sandvik L, Mowinckel MC, Andersen TO, Qvigstad E, Sandset PM.
    Thromb Res; 2007 Apr 01; 120(3):371-9. PubMed ID: 17156824
    [Abstract] [Full Text] [Related]

  • 11. Effects of conjugated equine estrogen vs. raloxifene on serum insulin-like growth factor-i and insulin-like growth factor binding protein-3: a 2-year, double-blind, placebo-controlled study.
    Duschek EJ, de Valk-de Roo GW, Gooren LJ, Netelenbos C.
    Fertil Steril; 2004 Aug 01; 82(2):384-90. PubMed ID: 15302288
    [Abstract] [Full Text] [Related]

  • 12. Procoagulant state after raloxifene therapy in postmenopausal women.
    Azevedo GD, Franco RF, Baggio MS, Maranhão TM, Sá MF.
    Fertil Steril; 2005 Dec 01; 84(6):1680-4. PubMed ID: 16359964
    [Abstract] [Full Text] [Related]

  • 13. The effects of short-term raloxifene therapy on fibrinolysis markers: TAFI, tPA, and PAI-1.
    Ozeren M, Karahan SC, Ozgur M, Eminagaoglu S, Unsal M, Baytan S, Bozkaya H.
    Acta Obstet Gynecol Scand; 2005 Oct 01; 84(10):987-91. PubMed ID: 16167916
    [Abstract] [Full Text] [Related]

  • 14. [Effects of raloxifene combined with conjugated equine estrogen on prothrombotic state in ovariectomized rats].
    Gao H, Xi S, Xu L.
    Zhonghua Fu Chan Ke Za Zhi; 2013 Dec 01; 48(12):935-8. PubMed ID: 24495689
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.